A Safety and Immune Response Study to Evaluate Varying Doses of an mRNA Vaccine Against Coronavirus Disease 2019 (COVID-19) in Healthy Adults
Clinical trial NCT05972993 · COMPLETED
Trial details
- NCT number
- NCT05972993
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-08-07
- Primary completion
- 2024-05-09
- Enrollment
- 114
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.